home All News open_in_new Full Article

UCB’s Bimzelx and AbbVie’s Rinvoq Lead in EU5 Psoriatic Arthritis, Ankylosing Spondylitis, and Non

New insights from Spherix Global Insights reveal strong rheumatologist anticipation for next-generation oral and multi-pathway innovations, including Sotyktu, icotrokinra, and sonelokimab. Exton, PA, Nov. 13, 2025 (GLOBE NEWSWIRE) — The 2025 Market Dynamix™: Psoriatic Arthritis and Ankylosing Spondylitis/Non-Radiographic Axial Spondyloarthritis (EU5) studies from Spherix Global Insights reveal a rapidly evolving treatment landscape, as rheumatologists expand […]


today 4 d. ago attach_file Culture

attach_file Transport
attach_file Other
attach_file Society
attach_file Society
attach_file Other
attach_file Other
attach_file Culture
attach_file Other
attach_file Economics
attach_file Other
attach_file Economics
attach_file Other
attach_file Events
attach_file Culture
attach_file Other
attach_file Science
attach_file Economics
attach_file Politics
attach_file Transport
attach_file Economics


ID: 3860275516
Add Watch Country

arrow_drop_down